Braxia Scientific Announces Change in Directors and CEO | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – October 10, 2024) – Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) (“Braxia”, or the “Company”), is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders held on Wednesday, October 9, 2024. A total of 9.9% of the issued and outstanding common shares…

Ascend Wellness Refinances Debt

Ascend Wellness Holdings Signs Definitive Agreements to Issue $235 Million of Senior Secured Notes ~ Secures funding with 12.75% coupon and a 5-year term ~~

July 15, 2024

Children With IBD Showed Impaired Growth Before Diagnosis

Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index (BMI) in the years before diagnosis,

January 18, 2025

WHO greenlights Takeda’s dengue vaccine as company plans to ‘re-engage’ with FDA

The World Health Organization prequalified Takeda’s new dengue vaccine on Wednesday, a year after the company withdrew its FDA application for the candidate — though

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.